APYX
Apyx Medical
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Signals Analysis
Buy signal 2
Sell signal 0
Revenue Beats Expectation
EPS Beats Expectation
Key Stats
--DAY`S RANGE--
--52 WK RANGE--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
About APYX
Apyx Medical Corporation
The manufacturer of a proprietary helium plasma and radiofrequency technology
Healthcare Equipment and Supplies
Invalid Date
01/02/2019
NASDAQ Stock Exchange
220
12-31
Common stock
5115 Ulmerton Road, Clearwater, FL 33760
--
Apyx Medical Corporation was founded in Delaware in 1982. The company is an advanced energy technology company keen to enhance people's lives through innovative products, including helium plasma technology products sold under the name of Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgery market. Renuvion and J-Plasma provide surgeons with a unique ability to deliver controlled heat to the tissue to achieve the desired results. The company also leverages its deep expertise and decades of experience in unique waveforms through foundry agreements with other medical device manufacturers.
Company Financials
EPS
APYX has released its 2024 Q4 earnings. EPS was reported at -0.12, versus the expected -0.16, beating expectations. The chart below visualizes how APYX has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
APYX has released its 2024 Q4 earnings report, with revenue of 14.22M, reflecting a YoY change of -3.00%, and net profit of -4.66M, showing a YoY change of 51.59%. The Sankey diagram below clearly presents APYX’s revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
